144 related articles for article (PubMed ID: 36478259)
1. Immunohistochemical analysis of the distribution of RANKL: a case of disseminated carcinomatosis of bone marrow as the first presentation of relapse in curatively resected colorectal cancer.
Shimada Y; Nagaba Y; Okawa H; Ehara K; Okada S; Naito M; Yokomori H
Med Mol Morphol; 2023 Jun; 56(2):138-143. PubMed ID: 36478259
[TBL] [Abstract][Full Text] [Related]
2. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction.
Kusumoto H; Haraguchi M; Nozuka Y; Oda Y; Tsuneyoshi M; Iguchi H
Oncol Rep; 2006 Oct; 16(4):735-40. PubMed ID: 16969487
[TBL] [Abstract][Full Text] [Related]
3. Disseminated Carcinomatosis of Bone Marrow in an African Man with Metastatic Descending Colon Carcinoma.
Chuwa H; Kassam NM; Wambura C; Sherman OA; Surani S
Cureus; 2020 Apr; 12(4):e7593. PubMed ID: 32399327
[TBL] [Abstract][Full Text] [Related]
4. Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study.
Vogelaar FJ; van Pelt GW; van Leeuwen AM; Willems JM; Tollenaar RA; Liefers GJ; Mesker WE
Cell Oncol (Dordr); 2016 Dec; 39(6):537-544. PubMed ID: 27613548
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of isolated disseminated carcinomatosis of bone marrow from colorectal cancer.
Chan WK; Lin NS; Tay KV; Teo LT
ANZ J Surg; 2023 May; 93(5):1169-1175. PubMed ID: 36772885
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
7. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
[TBL] [Abstract][Full Text] [Related]
8. Disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation as the first symptom of recurrent rectal cancer successfully treated with chemotherapy: A case report and review of the literature.
Takeyama H; Sakiyama T; Wakasa T; Kitani K; Inoue K; Kato H; Ueda S; Tsujie M; Fujiwara Y; Yukawa M; Ohta Y; Inoue M
Oncol Lett; 2017 Jun; 13(6):4290-4294. PubMed ID: 28599429
[TBL] [Abstract][Full Text] [Related]
9. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
[No Abstract] [Full Text] [Related]
10. [A Case of Disseminated Carcinomatosis of the Bone Marrow with Carcinoma of the Rectum Diagnosed by Disseminated Intravascular Coagulation].
Tanaka H; Matsutani S; Iwauchi T; Uchima Y; Miyamoto H; Okada T; Tsujio G; Kurihara S; Nagashima D; Hirakawa T; Hirata K; Morimoto J; Yamagata S; Takeuchi K
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2219-2221. PubMed ID: 33468913
[TBL] [Abstract][Full Text] [Related]
11. Rectal cancer with disseminated carcinomatosis of the bone marrow: report of a case.
Nakashima Y; Takeishi K; Guntani A; Tsujita E; Yoshinaga K; Matsuyama A; Hamatake M; Maeda T; Tsutsui S; Matsuda H; Fujihara M; Ishida T
Int Surg; 2014; 99(5):518-22. PubMed ID: 25216414
[TBL] [Abstract][Full Text] [Related]
12. RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma.
Roux S; Meignin V; Quillard J; Meduri G; Guiochon-Mantel A; Fermand JP; Milgrom E; Mariette X
Br J Haematol; 2002 Apr; 117(1):86-92. PubMed ID: 11918537
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
[TBL] [Abstract][Full Text] [Related]
14. Disseminated tumour cells as a prognostic biomarker in colorectal cancer.
Flatmark K; Borgen E; Nesland JM; Rasmussen H; Johannessen HO; Bukholm I; Rosales R; Hårklau L; Jacobsen HJ; Sandstad B; Boye K; Fodstad Ø
Br J Cancer; 2011 Apr; 104(9):1434-9. PubMed ID: 21448171
[TBL] [Abstract][Full Text] [Related]
15. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
Möhrmann L; Zowada MK; Strakerjahn H; Siegl C; Kopp-Schneider A; Krunic D; Strunk D; Schneider M; Kriegsmann M; Kriegsmann K; Herbst F; Ball CR; Glimm H; Dieter SM
Int J Cancer; 2020 Jul; 147(2):519-531. PubMed ID: 32077087
[TBL] [Abstract][Full Text] [Related]
16. Disseminated carcinomatosis of the bone marrow from pancreatic cancer: a case report.
Namikawa H; Takemoto Y; Makuuchi A; Kobayashi M; Kinuhata S; Morimura M; Ikebe T; Tanaka H; Shuto T
BMC Cancer; 2016 Oct; 16(1):801. PubMed ID: 27769217
[TBL] [Abstract][Full Text] [Related]
17. Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.
Koch M; Kienle P; Hinz U; Antolovic D; Schmidt J; Herfarth C; von Knebel Doeberitz M; Weitz J
Ann Surg; 2005 Feb; 241(2):199-205. PubMed ID: 15650626
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases.
Todenhöfer T; Hennenlotter J; Schmiedel BJ; Hohneder A; Grimm S; Kühs U; Salih HR; Bühring HJ; Fehm T; Gakis G; Blumenstock G; Aufderklamm S; Schilling D; Stenzl A; Schwentner C
Prostate; 2013 Jan; 73(2):162-8. PubMed ID: 22715006
[TBL] [Abstract][Full Text] [Related]
19. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
